⌘K

Home/Filings/4/0000875320-25-000099

4//SEC Filing

ALTSHULER DAVID 4

Accession 0000875320-25-000099

CIK 0000875320other

View on SEC.gov Company Profile

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 4:07 PM ET

Size

4.7 KB

Accession

0000875320-25-000099

Insider Transaction Report

Form 4

Period: 2025-02-20

VERTEX PHARMACEUTICALS INC / MAVRTX

ALTSHULER DAVID

Director

Transactions

Sale
Common Stock
2025-02-20$480.00/sh−1,111$533,280→ 45,019 total

Footnotes (1)

[F1]Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1, which was entered into on 8/8/2024.

Documents

1 file

4
wk-form4_1740431255.xmlPrimary
FORM 4

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001550395

Filing Metadata

Form type: 4
Filed: Feb 23, 7:00 PM ET
Accepted: Feb 24, 4:07 PM ET
Size: 4.7 KB

View on SEC.gov